Trials 360, CRO’s Post

Read our new publication on transforming the clinical trials enterprise and enabling the future workforce to better support the evolving needs of drug research and development – one that is resilient, culturally aware, anti-racist, and interdisciplinary. The publication explores the expertise and disciplines needed to diversify and bolster capacity by 2030. Read now: https://ow.ly/WVG650RXobY #DrugForum #ClinicalTrials #Workforce #DiversityinSTEM

Read our new publication on transforming the clinical trials enterprise and enabling the future workforce to better support the evolving needs of drug research and development – one that is resilient, culturally aware, anti-racist, and interdisciplinary. The publication explores the expertise and disciplines needed to diversify and bolster capacity by 2030. Read now: https://ow.ly/PEFP50RHwB2 #DrugForum #ClinicalTrials #Workforce #DiversityinSTEM

Bringing promising treatments to market is full of complex decisions - from optimizing study design, to knowing when to move a drug forward, to best positioning your therapy in regulatory and market access conversations. Today at Medidata NEXT Basel 2024, Uwe Schuehly, Tanmay Jain and Eleanor McLaurin discussed how historical clinical trial data and synthetic data generated from it, can be a powerful tool in generating evidence to bolster confidence and improve the likelihood of successfully advancing your development plan in the session on Balancing Risk and Benefit: Designing Safer Trials for Patients While Meeting Evidence Requirements of Regulators #medidatanext #clinicaltrials #lifesciences #medidata

Selecting the correct endpoint for a clinical trial is critical. It drives the design, execution, and ultimate relevance of your research. 5 ESSENTIAL questions to keep in mind when defining your trial’s endpoints: 1️⃣ Is it Clinically Relevant? Does your endpoint reflect a meaningful benefit for patients? Will it improve health outcomes or quality of life? 2️⃣ Can it Be Measured Accurately? Do you have the tools and methods to measure the endpoint consistently and precisely? Is it quantifiable and validated? 3️⃣ Does it Meet Regulatory Expectations? Have you reviewed guidelines from regulators? Does your endpoint align with what these agencies look for? 4️⃣ Is it Feasible? Can your trial realistically achieve this endpoint within the given timeline, budget, and resources? 5️⃣ Does it Address Safety and Risk-Benefit? Will your endpoint provide clear safety profile of your treatment? Your endpoint is not just a scientific decision, but a strategic one! 🎯 What questions do you ask? #ClinicalTrials #Biotech #ClinicalResearch #DrugDevelopment #ClinicalEndpoints #ClinicalStrategy

Fact: Just 10-15% of new treatments successfully make it to market. Fact: With next-gen clinical development capabilities, life sciences organizations can increase their probability of success by 15% or more. In our latest POV 👇https://bit.ly/3TZXnAZ, David Ghesquieres explores how life sciences organizations can build advanced digital and data capabilities to enable innovative trial designs, driving success and time-to-market across the drug development lifecycle. #lifesciences #clinicaldevelopment #innovation

✨ The world of clinical research is evolving faster than ever before. Rapid technological advancements, changing regulations, and growing patient-centric approaches are just a few of the forces shaping the industry today. 🔎 At PAM Pharm, we have a unique perspective on these global trends. Operating across North American and European markets, we navigate diverse regulatory landscapes, ensuring that clinical trials are conducted efficiently, ethically, and with the highest standards of quality. But it’s not just about keeping up - it’s about leading the way. Our team constantly adapts to emerging trends such as AI-powered data analysis, decentralized trials, and the growing emphasis on sustainability. This allows us to not only stay ahead of industry changes but also to actively shape the future of clinical research. 👉 We partner with companies to implement cutting-edge solutions tailored to the ever-changing global clinical research environment. Whether it’s optimizing supply chains, managing risks, or improving patient outcomes, PAM Pharm is here to turn challenges into opportunities.

The Hawthorne Effect: When study participants change their behavior simply because they know they're being observed. 🤔 For clinical trials, this can mean skewed data, inaccurate results, and wasted resources. 📉 But what if your data could stay pure, unbiased, and truly reflective of real-world conditions? 💡 With our cough monitoring technology, you get accurate, unobtrusive, and privacy-preserving cough data collection – no Hawthorne Effect. 🚫🎯 Ensure your trial outcomes are reliable and impactful. Choose technology that doesn’t interfere. ✅ #ClinicalTrials #Pharma #Research #DataAccuracy #CoughMonitoring #Innovation

Karen Chu, HiRO's CEO, highlights our expertise in guiding biotechs through early-stage clinical research planning. From choosing the right country for trials to navigating regulatory landscapes, HiRO acts as a strategic 'GPS' for our clients. Discover how our experienced team streamlines the path to successful cross-border collaboration. Hashtags: #HiRO #ClinicalDevelopment #BiotechStrategy #GlobalResearch #HealthcareInnovation #ClinicalTrials

The article “Assessing the Net Financial Benefits of Employing Digital Endpoints in Clinical Trials” conducted “a comprehensive assessment of the financial net benefits of digital endpoints in clinical trials” and demonstrated that “the use of digital endpoints in clinical trials can provide substantial extra value to sponsors developing new drugs, with high ROIs”, with phase III trials demonstrating substantial increases in expected net present value (eNPV) and return on investment (ROI). Koneksa, supports and collaborates with the community to advance these technologies and further leverage their benefits in clinical research. Read the full article here:https://lnkd.in/eSEe8p_Y #DigitalEndpoints #ClinicalTrials #DigitalBiomarkers

Dive into our latest blog exploring the pivotal role of data storage and performance in driving technological breakthroughs, especially in healthcare. Discover how effective data analytics is shaping life sciences and pharma—from research and development to clinical trials. Read more: https://lnkd.in/gixfACYV #phison #healthcare #ssd #technologyinhealthcare